iShares Biotechnology ETF $IBB Shares Acquired by Truist Financial Corp

Truist Financial Corp boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 2,239.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 642,023 shares of the financial services provider’s stock after buying an additional 614,582 shares during the quarter. Truist Financial Corp’s holdings in iShares Biotechnology ETF were worth $108,354,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $25,000. Cornerstone Planning Group LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $35,000. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $36,000. Parkside Financial Bank & Trust lifted its stake in iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares during the last quarter. Finally, Close Asset Management Ltd boosted its holdings in iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.7%

iShares Biotechnology ETF stock opened at $170.16 on Tuesday. iShares Biotechnology ETF has a 12 month low of $116.25 and a 12 month high of $179.64. The company has a fifty day moving average price of $169.84 and a two-hundred day moving average price of $168.65.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.